top border
top border
Featured Programs
Therapeutic Inhibition of XPO1-Mediated Nucleocytoplasmic Transport With SINE Technology
Cancer is a complex disease characterized by uncontrolled cell growth and metastatic dissemination of tumor cells. View Now

This expert panel discussion led by Keith Stewart, MB, CHB, focuses on clinical issues in the management of multiple myeloma, including risk assessment, approaches to newly diagnosed and relapsed disease, and transplant. The panel discussants are Ajai Chari, MD; Sagar Lonial, MD; Paul G. Richardson, MD; and Jatin J. Shah, MD. View Now

 

Featured Video
Dr. Esteva on the Future of Biosimilars in Breast Cancer
Francisco J. Esteva, MD, PhD, director, breast medical oncology program, Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, discusses the future use of biosimilars in breast cancer within the United States. View now
Kristi Rosa

Gina Columbus highlights the latest news from the 2019 ASH Annual Meeting in this week's OncLive News Network.

Publication Bottom Border
Border Publication
x